BCM
BIOS Capital Management Portfolio holdings
AUM
$88.9M
1-Year Est. Return
16.17%
1 Year Est. Return
+16.17%
AUM
$88.9M
AUM Growth
+$16.3M
(+23%)
Holding
6
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ACTU
1
Actuate Therapeutics
ACTU
$162M
| $67.2M | 75.62% |
10,049,996
+84,917
|
|
||
2
Cognition Therapeutics
CGTX
$134M
| $8.1M | 9.11% |
6,000,000
|
|
||
|
IRD
3
Opus Genetics
IRD
$148M
| $6.59M | 7.42% |
3,683,429
|
|
||
4
Lantern Pharma
LTRN
$37.2M
| $4.42M | 4.97% |
1,015,715
-60,237
|
|
||
|
RNTX
5
Rein Therapeutics
RNTX
$35.5M
| $1.94M | 2.19% |
1,690,751
|
|
||
6
IN8bio
INAB
$6.95M
| $622K | 0.7% |
286,664
|
|